By Ryan Davis (August 9, 2010, 2:48 PM EDT) -- Merck & Co. Inc. has become the latest pharmaceutical company to be investigated by the U.S. government for possible violations of the Foreign Corrupt Practices Act.
In a filing with the U.S. Securities and Exchange Commission on Friday, the Whitehouse Station, N.J.-based drugmaker said it had received letters from both the SEC and the U.S. Department of Justice seeking information about its activities in "a number of countries" related to the anti-bribery law.
"The company is cooperating with the agencies in their requests and believes that this inquiry is part of a broader review of pharmaceutical industry practices in foreign countries,"...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!